EVAX (Evaxion AS) Net Margin %: 0.00% (As of Mar. 2026)


EVAX Evaxion AS EVAX
22 GF Score
Price $3.23
! 2 Warning Signs
View Full Analysis

What is Evaxion AS Net Margin %?

Evaxion AS EVAX -1.59% 22 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates EVAX with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Evaxion AS ranks worse than 54.33% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Evaxion AS's Net Income for the three months ended in Mar. 2026 was $-3.63 Mil. Evaxion AS's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Evaxion AS's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Evaxion AS's Net Margin % or its related term are showing as below:

EVAX' s Net Margin % Range Over the Past 10 Years
Min: -30308.22   Med: -316   Max: -102.38
Current: -129.63

EVAX's Net Margin % is ranked worse than
54.33% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs EVAX: -129.63

Evaxion AS  (NAS:EVAX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Evaxion AS Net Margin % Related Terms

Evaxion AS Net Margin % Historical Data

* Premium members only.

The historical data trend for Evaxion AS's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evaxion AS Net Margin % Chart

Evaxion AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -30,308.22 -316.00 -102.38

Evaxion AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -13,056.76 61.64 0.00 0.00

EVAX vs DARE, LITS, TVGN: Net Margin % Comparison

For the Biotechnology subindustry, Evaxion AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evaxion AS Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evaxion AS's Net Margin % distribution charts can be found below:

* The bar in red indicates where Evaxion AS's Net Margin % falls into.


EVAX
22GF Score
Evaxion AS EVAX
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evaxion AS Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Evaxion AS's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.707/7.528
=-102.38 %

Evaxion AS's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.629/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Evaxion AS (EVAX) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Evaxion AS and its competitors. According to the industry distribution chart, Evaxion AS ranks #514 out of 946 companies in the Biotechnology industry, placing it in the top 54.3%.
Is Evaxion AS's Net Margin % too high?
Evaxion AS's current Net Margin % is 0.00%. Based on the distribution chart, Evaxion AS ranks #514 out of 946 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Evaxion AS has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Evaxion AS's Net Margin % compare to DARE and LITS?
According to the Biotechnology industry distribution chart, Evaxion AS ranks #514 out of 946 companies for Net Margin %. This places Evaxion AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Evaxion AS and its competitors. Evaxion AS's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evaxion AS stock overvalued right now?
Evaxion AS (EVAX) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Evaxion AS's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Evaxion AS (EVAX), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evaxion AS Business Description

Address Dr. Neergaards Vej 5f, Horsholm, DNK, 2970
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
22GF Score

Get the complete analysis for EVAX

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.23
Price